Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

6th Antifibrotic Drug Development Summit (AFDD)

Evvnt Promotion / evvnt
Archivio
-
09.11.2022 - 11.11.2022  Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Rd, 01801 Woburn, USA
Time: 8:25 am to 5:00 pm
 
Temi della conferenza
Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF, NASH, CKD and more in one place at one time, so you can advance the progress of your antifibrotic therapies.
Scientific organizer
Hanson Wade
Annotazioni
Speakers: Adi Mor Chief Scientific Officer Chemomab, Akshay Krishnamurty Senior Scientist, Cancer Immunology Genentech, Andrew Leask Professor University of Saskatchewan, Andrzej Krolewski Senior Investigator Joslin Diabetes Centre
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1241066-2?pid=4832
Ms. Jessica Durston
 
Categorie
Servizi sanitari
Lingua
Inglese
Quote del Congresso
USD 2199.00 - USD 5696.00
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Anästhesie in Entwicklungsländern e. V.AMREF - African Medical and Research FoundationOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärztekammer für WienÖsterreichische Akademie der ÄrztenewTreeCenter of ExcellenceCharité International Academy